Medicare's innovation center plans to put more emphasis on empowering consumers to make personal choices in health care, and on promoting healthier lifestyles to prevent diseases, officials wrote in a strategy memo released Tuesday.
Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing Crispr therapies.
Vicarious and SS marked progress toward bringing their robotic surgery systems to the U.S. market. The companies are among a new generation of robot developers looking to challenge Intuitive Surgical.
The IPO market has been largely dormant across the tech sector for the past three years, and within digital health, it’s been almost completely dead. After President Donald Trump announced a sweeping tariff policy that plunged U.S. markets into turmoil last month, taking a company public is an even riskier endeavor. Online lender Klarna delayed its long-anticipated IPO, as did ticket marketplace StubHub.